机构

• 上海药物研究所 [11]
• 合肥物质科学研究院 [11]
• 武汉物理与数学研究所 [1]
• 自动化研究所 [1]
• 上海生物化学与细胞生... [1]

采集方式

• OAI收割 [25]

内容类型

• 期刊论文 [25]

发表日期

• 2023 [2]
• 2022 [2]
• 2021 [5]
• 2020 [6]
• 2019 [1]
• 2018 [3]
• 更多

学科主题

• Oncology [1]

筛选

浏览/检索结果: 共25条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer 期刊论文  OAI收割 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 卷号: 8, 期号: 1, 页码: 13 作者:  Zhou, Ji;  Zhang, Xu-Chao;  Xue, Shan;  Dai, Mengdi;  Wang, Yueliang   |  收藏  |  浏览/下载：12/0  |  提交时间：2023/10/17 Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells 期刊论文  OAI收割 Signal Transduction and Targeted Therapy, 2023, 卷号: 8, 期号: 6, 页码: 3013-3028 作者:  Wang, Ziruoyu;  Li, Yanan;  Zhao, Wensi;  Jiang, Shuai;  Huang, Yuqi   |  收藏  |  浏览/下载：9/0  |  提交时间：2024/03/27 Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文  OAI收割 GENES CHROMOSOMES & CANCER, 2022 作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping   |  收藏  |  浏览/下载：71/0  |  提交时间：2022/05/16 BRAF mutation  immune checkpoint inhibitors  non-small cell lung cancer  PD-L1  targeted therapy   Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements 期刊论文  OAI收割 NPJ PRECISION ONCOLOGY, 2022, 卷号: 6 作者:  Zhang, Yongchang;  Huang, Zhe;  Zeng, Liang;  Zhang, Xiangyu;  Li, Yizhi   |  收藏  |  浏览/下载：41/0  |  提交时间：2022/05/05 Quality of Life and Subgroup Analysis in a Phase 3 Randomized Study of Ensartinib vs Crizotinib in ALK-Positive NSCLC Patients: eXalt3. 期刊论文  OAI收割 JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16 作者:  Selvaggi, G.;  Wu, Y.;  Wang, Z.;  Wu, G.;  Poddubskaya, E.   |  收藏  |  浏览/下载：119/0  |  提交时间：2021/05/17 ALK  NSCLC  ensartinib   Noncanonical Gene Fusions Detected at the DNA Level Necessitate Orthogonal Diagnosis Methods Before Targeted Therapy 期刊论文  OAI收割 JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16 作者:  Song, Zhengbo;  Lu, Chenyu;  Xu, Chun-Wei;  Zheng, Zongli   |  收藏  |  浏览/下载：22/0  |  提交时间：2021/05/17 Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2021, 卷号: 10 作者:  Cai, Lei;  Wang, Jiangfeng;  Yan, Junrong;  Zeng, Jian;  Zhu, Liang   |  收藏  |  浏览/下载：30/0  |  提交时间：2021/03/15 invasive mucinous adenocarcinoma  surgical resection  next generation sequencing  genomic profiling  prognostic biomarker   Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2021, 卷号: 10 作者:  Cai, Lei;  Wang, Jiangfeng;  Yan, Junrong;  Zeng, Jian;  Zhu, Liang   |  收藏  |  浏览/下载：22/0  |  提交时间：2021/03/15 invasive mucinous adenocarcinoma  surgical resection  next generation sequencing  genomic profiling  prognostic biomarker   A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib 期刊论文  OAI收割 CLINICAL LUNG CANCER, 2021, 卷号: 22 作者:  Chen, Kaiyan;  Zhang, Fanrong;  Pan, Guoqiang;  Sheng, Jiamin;  Ye, Junyi   |  收藏  |  浏览/下载：45/0  |  提交时间：2021/03/15 Crizotinib  MET  Non-small-cell lung cancer  RET  Resistance   Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) POSITIVE NSCLC Patients: eXalt3 期刊论文  OAI收割 JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15 作者:  Selvaggi, G.;  Wakelee, H. A.;  Mok, T.;  Wu, Y. -L.;  Reck, M.   |  收藏  |  浏览/下载：127/0  |  提交时间：2020/11/30 ALK plus NSCLC  ensartinib  Crizotinib